About This Series

This video series introduces healthcare professionals to the fundamentals of oncology clinical trials. Participants will learn about trial design, conduct, ethics, regulatory requirements, data management, and career pathways in clinical research.

What You'll Learn

  • Oncology clinical trial design and implementation
  • Regulatory and ethical considerations
  • Data management and research operations
  • Challenges and opportunities in clinical research
  • Biomarkers, correlative studies, and related research methodologies

Intended Audience

  • Fellows and faculty interested in oncology clinical research
  • Oncology Advanced Practice Providers (APPs)
  • Learners from oncology-related specialties, including medical, hematologic, gynecologic, urologic, pediatric, surgical, head and neck, and radiation oncology

 

Available Videos

To view the videos, you will need an account on the UNCLCN Learning Portal. Log in or create an account before you get started.

2026 Series

Strengthening Representation in Clinical Research: Approaches to Increase Enrollment of Underrepresented Populations
- Marjory Charlot, MD, MPH, MSc and Carrie B. Lee, MD, MPH

What It Means To Be the Pl of an Oncology Clinical Trial
- Claire Dees, MD, MSc, ScM and Shaw Scott, JD

Statistics in Oncology Clinical Trials
- Anastasia Ivanova, PhD and Allison Deal, MS

Working with industry/ IIT with industry and IIT with in house products
- Jared Weiss, MD

Tissue Based Endpoints, Biomarkers, Exploratory Endpoints
- Philip M. Spanheimer, MD and Ryan Robinson

NCI Cooperative Groups: Why They Matter
- Siddharth Sheth, DO, MPH

Geriatric Assessment (GA) – measures, databases and studies
- Kirsten A. Nyrop, PhD

Clinical Research in Pediatric Cancer: Navigating Ethical, Operational, and Funding Challenges
- Thomas Alexander, MD, MPH

Everything a PI Needs to Know about Holding an IND
- Allison Camp, PhD

Patient Reported Outcomes in Clinical Trials
- Matthew LeBlanc, PhD, RN

2021 Series

Oncology Phase I Clinical Trials: Issues and Challenges
- Claire Dees, MD, MSc, ScM and Shaw Scott, JD

Phase II/III Trial Design
- Matthew Milowsky, MD, FASCO

Interventional and Correlative Trial Resources, The Translational Research Pipeline: Regulatory, Informed Consent, Sample Collection
- Chris E. Hilliard, BS, CCRC

Interventional and Correlative Trial Resources, The Translational Research Pipeline: Sample processing, analysis, and publication
- Michele Hayward, RD

NCI CCSG and CPO: What’s our J.O.B?
- Carrie B. Lee, MD, MPH

Proposing Investigator-Initiated Clinical Trials (IITs)
- Jared Weiss, MD

Writing and Holding an IDN – IIT Development 
- Kaitlin Morrison, PhD

Clinical Trial Operations: CPO Pre-Award Finance
- Coleman Tew, MPA

Clinical Trial Operations: OnCore, Data Management, & More
- Mary O’Dwyer, MRP, CCRP

Clinical Trial Operations: Regulatory Affairs
- Shaw Scott, JD

Clinical Trial Operations: CPO Clinical Operations
- Stefanie Belanger, MHA, CCRP

Working with Investigational Assay Results
- Kaitlin Morrison, PhD and Kathryn Pietrosimone, Ph.D and Victoria Bae-Jump, MD and Lisa Carey, MD, ScM, FASCO

The Role of Advocates in Clinical Trials Research
- Patty Spears, BS, FASCO

Achieving Racial Equity in Clinical Trial Participation: Barriers & Solutions
- Marjory Charolot, MD, MPH, MSc

 

Disclaimer

The views expressed herein are those of the presenter, they do not necessarily reflect the views of the contracted organization, department, School of Medicine, nor the University of North Carolina at Chapel Hill.